5 January 2024 · Interactions with apixaban, dabigatran, edoxaban or rivaroxaban can result in increased risks of a bleed or thrombosis. We advise on management options.

5 January 2024 · It is important to understand the risks, mechanisms of interactions and actions to take when prescribing medicines with DOACs.

19 December 2022 · A number of resources are available to support the safe use of high-risk medicines. Healthcare professionals should ensure they are available for their patients

2 November 2021 · Thromboembolic disease management whilst breastfeeding is challenging. Warfarin is the preferred choice. Guidance on using DOACs is also provided.

1 July 2021 · A range of oral anticoagulant formulations are suitable for adults with swallowing difficulties.